Raj Vuppalanchi, MD, shares insights on saroglitazar, EPICS-III, and the future of personalized treatment for PBC.
Raj Vuppalanchi, MD
Advertisement
Raj Vuppalanchi, MD, is a Professor of Medicine, Director of Hepatology, and Associate Program Director at the Indiana University School of Medicine.
Articles by Raj Vuppalanchi, MD
A hepatologist discusses ALP response, fibrosis risk, and treatment optimization in PBC.
An EPICS-III study investigator discusses the mechanism of action of saroglitazar to treat patients with PBC.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Can We Stop Heart Failure at Its Source?
2
FDA Approves Furosemide Injection (Furoscix ReadyFlow) for Edema in HF, CKD
3
Sanofi Announces Discontinuation of Amlitelimab for Atopic Dermatitis
4
Lessons From a Career Dedicated to Transforming Heart Failure Care
5